CLOV stock · SERA stock

CLOV vs SERA

Clover Health Investments Corp (CLOV) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Sera Prognostics Inc (SERA) is a medical devices company listed on US.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.

CLOV currently screens at market cap $1.55B. SERA currently screens at market cap $89.1M.

Not investment advice. Open the CLOV and SERA stock pages for the full models.

Not investment advice.

Popular Stock Comparisons